MEDICAL DISCLAIMER:The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website.

Dural Arteriovenous Malformations

Learning objectives

  • Learning
  • Understand
  • Integrate
  • Reflect

  • A Dural AV Fistula is a shunt from a dural artery (meningeal or occipital) to a dural venous channel
  • These are acquired deficits not congenital like AVMS and potential cause of ICH and SAH
  • 10 % of all intracranial AVMS. Most common in females > males
  • Causes include head injury, open surgery and Cerebral venous sinus thrombosis.
  • These "fistulae" are extra axial direct connections between arterial flow and dural venous sinuses.
  • The result is flow, shunting, pressure effects and venous congestion and haemorrhage.
  • They lie within the dura mater most commonly with the transverse sinus
  • Carotid-cavernous sinus shunts cause chemosis and scleral injection and an audible bruit.
  • Lesions without cortical venous reflex almost never cause neurological deficits
  • Cavernous sinus behind the eye: chemosis, reduced acuity, bruit, swelling of the eye.
  • Transverse/sigmoid sinus behind ear: pulsating noise (tinnitus). Stroke like symptoms, seizure like activity, headaches.
  • Vertebral artery

  • Possibly asymptomatic, Dural pain fibres can lead to headache.
  • Seizures, bruits, headaches, stroke like episodes
  • Signs of increased intracranial pressure and bleeding.
  • Diagnosis is by Angiography - CTA/MRA/DSA. There is usually localised venous congestion with dilated cortical veins and vasogenic oedema. Angiography demonstrated early venous filling with arterial supply from external carotid artery branches.
  • Annual bleed risk is difficult to determine but felt to be less than 5% per annum.
  • Treatment options include conservative, endovascular embolisation using N-butyl-cyanoacryalate glue or other substance or surgery.